Inferior Vena Cava Filter Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

TheInferior Vena Cava Filter market is segmented by Application (Treatment of Venous Thromboembolism, Prevention of Pulmonary Embolism), Product Type (Retrievable, Permanent), End-User (Hospitals, Ambulatory Surgical Centers, Others), and Geography

Inferior Vena Cava Filter Market Snapshot

Inferior Vena Cava Filter Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 9.1 %
Inferior Vena Cava Filter Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

  • The Inferior Vena Cava Filter market studied is anticipated to grow with a CAGR of nearly 9.1%, during the forecast period.
  • Certain factors that are driving the market growth include rising prevalence of cardiac ailments and growing demand for minimally invasive techniques.
  • IVCF is indicated for patients who have suffered an acute venous thromboembolic event (VTE) and who cannot receive anticoagulation. IVCF is also commonly suggested for patients who are perceived to have failed anticoagulation.
  • Inferior vena cava filters (IVCF) have been developed with the intent of preventing pulmonary embolism (PE) and reducing venous thromboembolism (VTE) related mortality.
  • The prevalence of VTE is on a rise, across the globe. For instance, according to the Centers for Disease Control and Prevention (CDC), even though the precise number of people affected by VTE is unknown, however as many as 900,000 people could be affected (1 to 2 per 1,000) each year in the United States. The Inferior Vena Cava Filter market is anticipated to grow at a high rate owing to this increasing prevalence.
  • Nonetheless, IVCF are not devoid of complications. Serious complications such as IVC thrombosis occur in a non-negligible proportion of patients receiving these devices, more so in several high-risk populations such as metastatic cancer patients. Such factors are expected to hinder growth of the Inferior Vena Cava Filter market up to a certain extent.

Scope of the Report

Inferior vena cava filters (IVCF) are mechanical devices that are implanted by vascular surgeons or interventional radiologists into the inferior vena cava to prevent life-threatening pulmonary emboli. The trapped blood clots remain in the filter until the body is able to dissolve them. The procedure of IVCF is usually quick and simple to perform.

By Application
Treatment of Venous Thromboembolism
Prevention of Pulmonary Embolism
By Product Type
Retrievable
Permanent
By End-User
Hospitals
Ambulatory Surgical Centers
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Retrievable IVCF Shows Lucrative Growth in the Global Inferior Vena Cava Filter Market

  • Retrievable IVC filters have gradually become a more attractive option owing to the long-term risks of permanent filter placement. These devices are proved to be technically feasible in insertion and retrieval percutaneously while providing protection from PE.
  • The development of advanced filter retrieval techniques has had a significant impact on the removal of embedded RIVCFs, permitting retrieval of the majority of devices.
  • The approach to retrieving a RIVCF that is embedded or has had an extended implantation time has been significantly impacted by the development of advanced retrieval techniques. A recent study demonstrated that when advanced techniques are employed, RIVCFs can be successfully removed regardless of their dwell time.
  • A few of the FDA-approved retrievable IVC filters are Günther Tulip and Celect filters (Cook Medical), OptEase filter (Cordis Endovascular), and G2 and G2 Express filters (Bard Peripheral Vascular).
Inferior Vena Cava Filter Market Growth

North America Dominates the Global Inferior Vena Cava Filter Market

  • As per the National Center on Birth Defects and Developmental Disabilities, along with the Centers for Disease Control and Prevention, estimates suggest that 60,000-100,000 Americans die of venous thromboembolism.
  • 10 to 30% of people are projected to die within one month of diagnosis. Sudden death is the first symptom in about one-quarter (25%) of people who have a PE.
  • Among people who have had a VTE, 33% to 50% are likely to have long-term complications (post-thrombotic syndrome) such as swelling, pain, discoloration, and scaling in the affected limb. One-third (about 33%) of people with VTE are expected to have a recurrence within 10 years.
  • Around 5 to 8% of the U.S. population has one of several genetic risk factors, also known as inherited thrombophilias in which a genetic defect can be identified that increases the risk for thrombosis. This high prevalence of the ailments is expected to drive the market growth across the region.
Inferior Vena Cava Filter Market Analysis

Competitive Landscape

The global Inferior Vena Cava Filter market is competitive and consists of a few major players. Companies like ALN, Argon Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Braile Biomédica, Cardinal Health, Cook Medical, Volcano Corporation, among others, hold the substantial market share in the market.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Cardiac Ailments

      2. 4.2.2 Growing Demand of Minimally Invasive Techniques

    3. 4.3 Market Restraints

      1. 4.3.1 Risks associated with the Device Malfunction

      2. 4.3.2 Lack of Awareness in Developing Countries

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Application

      1. 5.1.1 Treatment of Venous Thromboembolism

      2. 5.1.2 Prevention of Pulmonary Embolism

    2. 5.2 By Product Type

      1. 5.2.1 Retrievable

      2. 5.2.2 Permanent

    3. 5.3 By End-User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 ALN

      2. 6.1.2 Argon Medical

      3. 6.1.3 B. Braun Melsungen AG

      4. 6.1.4 Becton, Dickinson and Company

      5. 6.1.5 Boston Scientific Corporation

      6. 6.1.6 Braile Biomedica

      7. 6.1.7 Cardinal Health

      8. 6.1.8 Cook Medical

      9. 6.1.9 Volcano Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Inferior Vena Cava Filter Market market is studied from 2018 - 2026.

The Inferior Vena Cava Filter Market is growing at a CAGR of 9.1% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Becton, Dickinson and Company , Boston Scientific Corporation , Cardinal Health , Cook Medical , B. Braun Melsungen AG are the major companies operating in Inferior Vena Cava Filter Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!